Daily Progress: AIM ImmunoTech Inc (AIM) Drop -8.07, Closing at 0.19

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

In the latest session, AIM ImmunoTech Inc (AMEX: AIM) closed at $0.19 down -8.07% from its previous closing price of $0.20. In other words, the price has decreased by -$8.07 from its previous closing price. On the day, 0.99 million shares were traded. AIM stock price reached its highest trading level at $0.1996 during the session, while it also had its lowest trading level at $0.1811.

Ratios:

For a deeper understanding of AIM ImmunoTech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.75. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 0.20.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 21 ’24 when Equels Thomas K bought 20,000 shares for $0.21 per share. The transaction valued at 4,240 led to the insider holds 1,657,968 shares of the business.

MITCHELL WILLIAM M sold 4,580 shares of AIM for $884 on Dec 19 ’24. The Director now owns 118,549 shares after completing the transaction at $0.19 per share. On Dec 18 ’24, another insider, Equels Thomas K, who serves as the CEO & President of the company, bought 22,727 shares for $0.21 each. As a result, the insider paid 4,682 and bolstered with 1,680,695 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AIM now has a Market Capitalization of 12559237 and an Enterprise Value of 6039479. For the stock, the TTM Price-to-Sale (P/S) ratio is 66.09 while its Price-to-Book (P/B) ratio in mrq is 3.74. Its current Enterprise Value per Revenue stands at 30.047 whereas that against EBITDA is -0.193.

Stock Price History:

The Beta on a monthly basis for AIM is -0.30, which has changed by -0.5454545 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, AIM has reached a high of $0.62, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -11.32%, while the 200-Day Moving Average is calculated to be -39.50%.

Shares Statistics:

For the past three months, AIM has traded an average of 640.95K shares per day and 859300 over the past ten days. A total of 67.67M shares are outstanding, with a floating share count of 59.62M. Insiders hold about 11.89% of the company’s shares, while institutions hold 13.35% stake in the company. Shares short for AIM as of 1730332800 were 491374 with a Short Ratio of 0.99, compared to 1727654400 on 590329. Therefore, it implies a Short% of Shares Outstanding of 491374 and a Short% of Float of 0.8500000000000001.

Most Popular